Skip to main content

ADVERTISEMENT

Rogério Sarmento-Leite, MD, PhD

08/01/2008
Drug-eluting stents (DES) significantly decrease the need for a new target vessel revascularization (TVR) after coronary intervention,1–4 but its widespread use is still limited by cost issues.5,6 DES are currently used in more than 70% of...
Drug-eluting stents (DES) significantly decrease the need for a new target vessel revascularization (TVR) after coronary intervention,1–4 but its widespread use is still limited by cost issues.5,6 DES are currently used in more than 70% of...
Drug-eluting stents (DES)...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
09/09/2008
ABSTRACT: Objective. Determine minimum inflation time necessary for total stent expansion and apposition. Background. Complete stent expansion is needed to adequately support the increase in artery lumen and to accommodate neointimal growth....
ABSTRACT: Objective. Determine minimum inflation time necessary for total stent expansion and apposition. Background. Complete stent expansion is needed to adequately support the increase in artery lumen and to accommodate neointimal growth....
ABSTRACT: Objective. Determine...
09/09/2008
Journal of Invasive Cardiology
Original Contribution
12/04/2009
ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at...
ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at...
ABSTRACT: Objective. Our aim was...
12/04/2009
Journal of Invasive Cardiology